The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease
Objective: To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…Combination of multimodal neuroimaging techniques is useful to diagnose multiple system atrophy
Objective: To determine whether multiple system atrophy (MSA) patients can be differentiated form Parkinson's disease (PD) patients using combination of multimodal neuroimaging techniques. Background: MSA…Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy
Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…Semi-automated MRI algorithm using susceptibility weighted imaging for differentiating multiple system atrophy with parkinsonism from Parkinson Disease
Objective: To investigate the diagnostic value of semi-automated diagnostic algorithm using 3T-MR susceptibility-weighted image (SWI) for multiple system atrophy with parkinsonism (MSA-p). Background: Iron deposition…The predictor factors for survival in Chinese Multiple System Atrophy patients
Objective: Our aim was to explore the predictors of survival in Chinese multiple system atrophy (MSA) patients. Background: MSA is a rare, fatal neurodegenerative disorder with…Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy
Objective: To identify MRI markers that are associated with more rapid clinical progression in multiple system atrophy (MSA) Background: The rate of clinical progression in…Depression, anxiety and quality of life in Multiple System Atrophy
Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…DaTscan in clinical evaluation of Multiple System Atrophy
Objective: To explore accuracy of DaTscanTM Ioflupane I123 Injection (DaTscan) in a multiple system atrophy (MSA) cohort Background: There are isolated cases of normal DaTscan in neuropathologically confirmed MSA-cerebellar subtype (MSA-C)…Gait characteristics in Atypical Parkinsonism
Objective: We investigated gait characteristics of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), with the aim to elucidate relatively specific disease differences in…MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials
Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 23
- Next Page »